StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
15
Publishing Date
2023 - 06 - 29
1
2023 - 04 - 26
1
2023 - 04 - 20
1
2023 - 04 - 18
1
2022 - 10 - 24
1
2022 - 10 - 19
1
2022 - 10 - 11
1
2022 - 09 - 28
2
2022 - 08 - 31
1
2022 - 07 - 26
1
2022 - 07 - 11
1
2022 - 06 - 07
1
2022 - 04 - 13
1
2022 - 04 - 12
1
Sector
Health technology
15
Tags
Agreement
1
Approval
1
Aqst-109
4
Business
2
Candidate
1
Collaboration
1
Conference
4
Epinephrine
3
Fda
3
Financial
2
License
1
Life
1
Medical
1
N/a
15
Positive
4
Report
2
Response
1
Results
3
Sciences
1
Tentative
1
Therapeutics
14
Topline
1
Trial
1
Update
1
Entities
Aquestive therapeutics, inc.
15
Symbols
AAPL
16
ABB
17
ABBV
15
ABLZF
15
AMRS
13
AQST
15
ARVL
71
BEEM
16
BHC
14
BMY
17
CETY
14
CMG
15
CNC
18
CRCW
16
CSCO
21
DFS
15
DZSI
14
ERIC
22
EXPR
19
F
18
FNCTF
126
GE
15
GOLD
18
HEPA
15
HON
15
IONS
14
IT
18
JAGX
15
JNJ
78
KKR
18
LAZR
14
LDNXF
15
LLY
29
LNSTY
15
LTUM
30
MACK
18
MMM
14
MRK
14
MRNA
15
MS
60
NKLA
21
NVO
16
NVS
16
NVSEF
14
OCX
16
ORCL
33
OTLK
18
PFE
16
PPRUF
21
PPRUY
21
SNY
72
SNYNF
70
STEP
16
STLA
20
TECH
16
TNXP
15
VSAT
15
VTRS
15
VZ
16
XYF
16
Exchanges
Nasdaq
15
Crawled Date
2023 - 06 - 29
1
2023 - 04 - 26
1
2023 - 04 - 20
1
2023 - 04 - 18
1
2022 - 10 - 24
1
2022 - 10 - 19
1
2022 - 10 - 11
1
2022 - 09 - 28
2
2022 - 08 - 31
1
2022 - 07 - 26
1
2022 - 07 - 11
1
2022 - 06 - 07
1
2022 - 04 - 13
1
2022 - 04 - 12
1
Crawled Time
00:00
1
02:00
2
03:00
1
04:00
1
04:20
1
05:09
1
06:00
1
08:20
1
09:08
20
11:00
1
12:00
16
12:01
1
12:03
1
12:15
4
12:20
15
13:00
24
13:04
1
13:15
1
13:20
7
13:30
3
14:00
8
15:15
2
15:30
1
16:00
1
17:00
1
18:00
2
18:09
1
19:00
1
20:00
5
21:00
13
22:00
8
23:00
1
Source
www.aquestive.com
12
www.globenewswire.com
2
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
Aqst
crawled time :
12:20
save search
Aquestive Therapeutics Provides Business Update and Announces Chief Medical Officer Appointment
Published:
2023-06-29
(Crawled : 12:20)
- globenewswire.com
AQST
|
$3.92
1.82%
1.8M
|
Health Technology
|
142.14%
|
O:
1.26%
H:
0.0%
C:
-1.24%
business
update
medical
therapeutics
Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences
Published:
2023-04-26
(Crawled : 12:20)
- aquestive.com
AQST
|
$3.92
1.82%
1.8M
|
Health Technology
|
200.78%
|
O:
1.56%
H:
0.77%
C:
-3.85%
therapeutics
Aquestive Therapeutics Receives Conditional FDA Acceptance of Proprietary Name Anaphylm™ for Lead Candidate AQST-109 (Epinephrine Sublingual Film)
Published:
2023-04-20
(Crawled : 12:20)
- aquestive.com
AQST
|
$3.92
1.82%
1.8M
|
Health Technology
|
178.99%
|
O:
1.45%
H:
2.86%
C:
-1.43%
aqst-109
fda
candidate
therapeutics
Aquestive Therapeutics to Report First Quarter 2023 Financial Results and Recent Business Highlights on May 2 and Host Conference Call on May 3 at 8:00 a.m. ET
Published:
2023-04-18
(Crawled : 12:20)
- aquestive.com
AQST
|
$3.92
1.82%
1.8M
|
Health Technology
|
180.0%
|
O:
1.82%
H:
1.43%
C:
-7.14%
conference
report
business
therapeutics
financial
results
Aquestive Therapeutics Announces Positive Decision in States’ Suboxone Antitrust Lawsuit on All Claims
Published:
2022-10-24
(Crawled : 12:20)
- aquestive.com
AQST
|
$3.92
1.82%
1.8M
|
Health Technology
|
327.83%
|
O:
3.0%
H:
0.33%
C:
-3.98%
therapeutics
positive
Aquestive Therapeutics to Report Third Quarter 2022 Financial Results and Recent Business Highlights on November 1 and Host Conference Call on November 2 at 8:00 a.m. ET
Published:
2022-10-19
(Crawled : 12:20)
- aquestive.com
AQST
|
$3.92
1.82%
1.8M
|
Health Technology
|
309.71%
|
O:
1.1%
H:
0.58%
C:
-7.86%
conference
report
therapeutics
financial
results
Aquestive Therapeutics Receives Positive FDA Written Response for AQST-109 Epinephrine Sublingual Film
Published:
2022-10-11
(Crawled : 12:20)
- aquestive.com
AQST
|
$3.92
1.82%
1.8M
|
Health Technology
|
277.45%
|
O:
1.96%
H:
8.65%
C:
3.85%
aqst-109
fda
therapeutics
response
epinephrine
positive
PHARMANOVIA ENTERS EXCLUSIVE LICENSING COLLABORATION FOR DIAZEPAM BUCCAL FILM
Published:
2022-09-28
(Crawled : 12:20)
- prnewswire.com
AQST
|
$3.92
1.82%
1.8M
|
Health Technology
|
237.72%
|
O:
-7.02%
H:
11.31%
C:
9.43%
collaboration
Aquestive Therapeutics Enters License and Supply Agreement with Pharmanovia for Libervant™ (diazepam) Buccal Film for European and MENA Markets
Published:
2022-09-28
(Crawled : 12:20)
- aquestive.com
AQST
|
$3.92
1.82%
1.8M
|
Health Technology
|
237.72%
|
O:
-7.02%
H:
11.31%
C:
9.43%
license
therapeutics
agreement
Aquestive Therapeutics Receives FDA Tentative Approval for Libervant™ (diazepam) Buccal Film
Published:
2022-08-31
(Crawled : 12:20)
- aquestive.com
AQST
|
$3.92
1.82%
1.8M
|
Health Technology
|
153.29%
|
O:
-6.58%
H:
3.52%
C:
1.76%
fda
tentative
approval
therapeutics
Aquestive Therapeutics to Participate in Wedbush PacGrow Healthcare Conference
Published:
2022-07-26
(Crawled : 12:20)
- aquestive.com
AQST
|
$3.92
1.82%
1.8M
|
Health Technology
|
346.12%
|
O:
-0.35%
H:
3.14%
C:
-6.4%
conference
therapeutics
Aquestive Therapeutics Reports Positive Results from Final Two Arms of EPIPHAST Trial Supporting Performance and Real-World Functionality of AQST-109 Epinephrine Oral Film
Published:
2022-07-11
(Crawled : 12:20)
- globenewswire.com
AQST
|
$3.92
1.82%
1.8M
|
Health Technology
|
408.45%
|
O:
0.37%
H:
19.74%
C:
7.89%
aqst-109
trial
therapeutics
epinephrine
positive
results
Aquestive Therapeutics to Participate in JMP Securities Life Sciences Conference
Published:
2022-06-07
(Crawled : 12:20)
- aquestive.com
AQST
|
$3.92
1.82%
1.8M
|
Health Technology
|
308.31%
|
O:
-3.49%
H:
0.78%
C:
-3.27%
sciences
conference
life
therapeutics
Aquestive Therapeutics Announces Common Stock Purchase Agreement for up to $40 Million with Lincoln Park Capital
Published:
2022-04-13
(Crawled : 12:20)
- aquestive.com
AQST
|
$3.92
1.82%
1.8M
|
Health Technology
|
78.24%
|
O:
0.0%
H:
10.65%
C:
2.78%
therapeutics
Aquestive Therapeutics Reports Positive Topline Data from Part 2 of EPIPHAST Trial Evaluating AQST-109 Epinephrine Oral Film
Published:
2022-04-12
(Crawled : 12:20)
- aquestive.com
AQST
|
$3.92
1.82%
1.8M
|
Health Technology
|
78.24%
|
O:
-1.85%
H:
6.6%
C:
1.89%
aqst-109
topline
therapeutics
epinephrine
positive
Gainers vs Losers
65%
35%
Top 10 Gainers
INVO
|
$2.93
285.53%
140M
|
Health Technology
RYDE
|
$4.66
70.7%
410K
|
n/a
EDBL
|
$7.4
62.64%
12M
|
VNDA
|
$5.28
30.37%
21M
|
Health Technology
VIRX
|
$0.912
27.59%
170K
|
Manufacturing
IGC
4
|
$0.6199
27.55%
1.9M
|
Health Technology
WISA
4
|
$7.72
26.56%
51M
|
Electronic Technology
GRTX
|
$0.2151
26.53%
8.3M
|
Health Technology
TCON
|
$2.135
24.85%
440K
|
Health Technology
AGFY
|
$0.37
24.2%
28M
|
Your saved searches
Save your searches and get alerts when important news are released.